CIK 0001824293
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
GRI Bio, Inc.
Sign in to watch- Ticker
- GRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 824369909
- Phone
- +1 619-400-1171
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
- Former names
- Vallon Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-18 | Hertz Walter Marc Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +103,067 | 103,067 | ||
| 2025-08-26 | Hertz Walter Marc Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +26,688 | 26,688 | ||
| 2025-01-23 | Hertz Walter Marc Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +129,730 | $0.69 | $89K | 129,730 |
| 2023-04-21 | Hertz Walter Marc Chief Executive Officer | Grant or award | +385,510 | 385,510 |
Page 1 of 1 · 4 trades